Unlock instant, AI-driven research and patent intelligence for your innovation.

Novel cyano-substituted dihydropyrimidine compounds and their use to treat diseases

A compound, cyano technology, applied in the field of new compounds

Inactive Publication Date: 2004-06-23
BRISTOL MYERS SQUIBB CO
View PDF0 Cites 2 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

Small molecule inhibitors of Eg5 that induce transient mitotic arrest are unlikely to be effective in the treatment of cancer cell proliferation

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Novel cyano-substituted dihydropyrimidine compounds and their use to treat diseases
  • Novel cyano-substituted dihydropyrimidine compounds and their use to treat diseases
  • Novel cyano-substituted dihydropyrimidine compounds and their use to treat diseases

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 15

[0132] Example 15-cyano-3,6-dihydro-4-methyl-6-(3-nitrophenyl)-2-thio-1-(2H)-pyrimidinecarboxylic acid ethyl ester

[0133] A. Step 1

[0134] A mixture of 6.42 g of acetoacetamide, 8.0 g of 3-nitrobenzaldehyde, 0.61 ml of acetic acid and 0.21 ml of piperidine in 30 ml of toluene was heated to reflux. Azeotropic water was removed using a Dean Stark trap. After reflux for 2 h, the reaction mixture was cooled to room temperature and a large amount of solid appeared, which was treated with a solution of 300 ml EtOAc and 25 ml MeOH, then the solid was filtered off and rinsed twice with 15 ml EtOAc to obtain 3.1 g of the desired product in 25% yield.

[0135] B. Step 2

[0136] A mixture of 200 mg of the product of step 1 of Example 1, 198 mg of 2-(4-methoxybenzyl)-2-thiopseudourea hydrochloride, and 84 mg of sodium acetate in 3.6 ml of DMF was heated at 85° C. for 15 h, and then Cool to room temperature. The resulting reaction mixture was purified by...

Embodiment 1

[0140] Add 17 μL of ethyl chloroformate to a solution of the compound (60 mg) and pyridine (0.1 ml) in Step 3 of Example 1 in 0.6 ml of dichloromethane, stir for 2.5 h, then add 22 μL of ethyl chloroformate, and stir the reaction mixture for 2 h, Then 0.3ml of trifluoroacetic acid was added, and the resulting mixture was stirred for another 1 h, concentrated in vacuo, diluted with DMF, methanol and a small amount of dichloromethane, filtered, and then purified by preparative HPLC (column: YMC S5 ODS 20×100mm) to obtain 22.5 mg product, yield 42.7%. MS(M-H) +=345. HPLC RT=2.85min (YMC S5 ODS column 4.6×50mm, 10-90% methanol aqueous solution containing 0.2% phosphoric acid, 4min, 4ml / min, monitored at 220nm)

Embodiment 25

[0141] Example 25-cyano-3,6-dihydro-4-methyl-6-(3-nitrophenyl)-2-oxo-1-(2H)-pyrimidinecarboxylic acid ethyl ester

[0142] A. Step 1

[0143] 10.92 g of sodium bicarbonate was added dropwise to a DMF (100 ml) solution of 7.83 g of the compound in Step 1 of Example 1 and 7.48 g of O-methylisourea hydrogensulfate, generating gas. The reaction mixture was stirred for 2 h, then heated at 65 °C overnight, cooled to room temperature, diluted with 800 ml EtOAc, washed with water (2 x 100 ml) and brine (1 x 100 ml). The organic layer was dried over magnesium sulfate, filtered and concentrated in vacuo. The resulting residue was triturated with ethyl acetate-dichloromethane-hexane to obtain 5.48 g of the desired solid product (56%).

[0144] B. Step 2

[0145] A mixture of Example 2 Step 1 compound (209mg) and Burgess reagent (274.5mg) in dichloromethane (5ml) and THF (10ml) was stirred overnight. The reaction mixture was concentrated in vacuo, diluted wit...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The present invention provides compounds of formula (I) and pharmaceutically acceptable salts thereof. The formula (I) compounds induce mitotic arrest thereby making them useful as anti-cancer agents. The formula (I) compounds are also useful for the treatment of other diseases which can be treated by inducing mitotic arrest.

Description

[0001] related application [0002] This application claims the benefit of US Provisional Patent Application No. 60 / 279,956, filed March 29, 2001, under 35 U.S.C Section 119(e). field of invention [0003] The present invention relates to novel compounds which prevent mitosis, making them useful in the treatment of proliferative diseases such as cancer. Background technique [0004] Cell proliferation and programmed cell death play an important role in the growth and development of organisms. In proliferative diseases such as cancer, the processes of cell proliferation and / or programmed cell death are often disturbed. For example, increased cell division in cancer cells may result from mutations that overexpress positive cell cycle regulators or lack negative cell cycle regulators. Alternatively, cancer cells may not be able to undergo programmed cell death due to the overexpression of negative regulators of ap...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): C07D239/36A61K31/505A61K31/506A61K31/513A61P9/14A61P35/00C07D211/90C07D239/22C07D239/40C07D239/42C07D401/04C07D401/10C07D403/10C07D403/12C07D405/04C07D409/04C07D409/06C07D409/10C07D413/04C07D413/10C07D413/14C07D417/04
CPCC07D413/10C07D211/90C07D239/22C07D409/04C07D403/10C07D401/10C07D409/10C07D409/06A61P35/00A61P9/14A61K31/495
Inventor S·D·金巴尔L·J·落姆巴多D·B·罗林斯H·Y·萧R·J·施米特D·K·威廉斯
Owner BRISTOL MYERS SQUIBB CO